Texas, USA-based Nanoscope Therapeutics has recently submitted a rolling biologics license application (BLA) to the Food and ...

The UK’s National Health Service (NHS) and local authorities have started the rollout of world-first gonorrhoea vaccination ...

Noom’s Microdose GLP-1Rx Program is priced at $119 to start, followed by $199 per month, which includes medication, if ...

Privately-held US clinical-stage biotech Cellergy Pharma announced the appointment Christopher Cano as chief executive (CEO).

Hungary’s largest drugmaker Gedeon Richter has announced the UK launch of Nalvee (10mg dydrogesterone), a highly bioavailable oral progestogen tablet for hormone replacement therapy (HRT).

A New York-based healthcare investment firm has announced that it has raised $1.86 billion in commitments for OrbiMed Royalty ...

Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...

Germany’s BioNTech has reported revenues for the second quarter 2025 of 260.8 million euros ($302 million), more than double ...

Biosimilars, once met with skepticism, are now an undeniable force in the global pharmaceutical market. As several ...

The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...

Shares of Vertex Pharmaceuticals plunged more than 14% to $404.89 after it release disappointing top-line results from its recently completed Phase II, randomized, double-blind, placebo-controlled ...

Philadelphia, USA-based Medicus Pharma and Boston-based biotech Helix Nanotechnologies have entered into a non-binding ...